Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma

被引:24
作者
Montfort, Anne [1 ]
Owen, Stephanie [2 ,3 ]
Piskorz, Anna M. [2 ]
Supernat, Anna [4 ]
Moore, Luiza [2 ,3 ]
Al-Khalidi, Sarwah [2 ]
Bohm, Steffen [1 ]
Pharoah, Paul [2 ,5 ]
McDermott, Jacqueline [1 ,6 ]
Balkwill, Frances R. [1 ]
Brenton, James D. [2 ,3 ,7 ]
机构
[1] Queen Mary Univ London, Baas Canc Inst, London, England
[2] Canc Res UK Cambridge Inst, Cambridge, England
[3] Univ Cambridge, Dept Oncol, Cambridge, England
[4] Med Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Translat Oncol, PL-80211 Gdansk, Poland
[5] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England
[6] Univ Coll London Hosp, Dept Pathol, London, England
[7] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
关键词
MISMATCH REPAIR GENES; LUNG-CANCER; T-CELLS; PROGNOSIS; BRCA1; STAGE; LYMPHOCYTES; METASTASES; MUTATIONS; LANDSCAPE;
D O I
10.1038/s41416-020-0822-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background In colorectal and breast cancer, the density and localisation of immune infiltrates provides strong prognostic information. We asked whether similar automated quantitation and combined analysis of immune infiltrates could refine prognostic information in high-grade serous ovarian carcinoma (HGSOC) and tested associations between patterns of immune response and genomic driver alterations. Methods Epithelium and stroma were semi-automatically segmented and the infiltration of CD45RO(+), CD8(+) and CD68(+) cells was automatically quantified from images of 332 HGSOC patient tissue microarray cores. Results Epithelial CD8 [p = 0.027, hazard ratio (HR) = 0.83], stromal CD68 (p = 3 x 10(-4), HR = 0.44) and stromal CD45RO (p = 7 x 10(-4), HR = 0.76) were positively associated with survival and remained so when averaged across the tumour and stromal compartments. Using principal component analysis, we identified optimised multiparameter survival models combining information from all immune markers (p = 0.016, HR = 0.88). There was no significant association between PTEN expression, type of TP53 mutation or presence of BRCA1/BRCA2 mutations and immune infiltrate densities or principal components. Conclusions Combining measures of immune infiltration provided improved survival modelling and evidence for the multiple effects of different immune factors on survival. The presence of stromal CD68(+) and CD45RO(+) populations was associated with survival, underscoring the benefits evaluating stromal immune populations may bring for prognostic immunoscores in HGSOC.
引用
收藏
页码:1803 / 1810
页数:8
相关论文
共 43 条
[1]   Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial [J].
Ali, H. R. ;
Dariush, A. ;
Thomas, J. ;
Provenzano, E. ;
Dunn, J. ;
Hiller, L. ;
Vallier, A. -L. ;
Abraham, J. ;
Piper, T. ;
Bartlett, J. M. S. ;
Cameron, D. A. ;
Hayward, L. ;
Brenton, J. D. ;
Pharoah, P. D. P. ;
Irwin, M. J. ;
Walton, N. A. ;
Earl, H. M. ;
Caldas, C. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1832-1835
[2]   Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[3]   TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma [J].
Biton, Jerome ;
Mansuet-Lupo, Audrey ;
Pecuchet, Nicolas ;
Alifano, Marco ;
Ouakrim, Hanane ;
Arrondeau, Jennifer ;
Boudou-Rouquette, Pascaline ;
Goldwasser, Francois ;
Leroy, Karen ;
Goc, Jeremy ;
Wislez, Marie ;
Germain, Claire ;
Laurent-Puig, Pierre ;
Dieu-Nosjean, Marie-Caroline ;
Cremer, Isabelle ;
Herbst, Ronald ;
Blons, Helene ;
Damotte, Diane .
CLINICAL CANCER RESEARCH, 2018, 24 (22) :5710-5723
[4]   Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma [J].
Bohm, Steffen ;
Montfort, Anne ;
Pearce, Oliver M. T. ;
Topping, Joanne ;
Chakravarty, Probir ;
Everitt, Gemma L. A. ;
Clear, Andrew ;
McDermott, Jackie R. ;
Ennis, Darren ;
Dowe, Thomas ;
Fitzpatrick, Amanda ;
Brockbank, Elly C. ;
Lawrence, Alexandra C. ;
Jeyarajah, Arjun ;
Faruqi, Asma Z. ;
McNeish, Iain A. ;
Singh, Naveena ;
Lockley, Michelle ;
Balkwill, Frances R. .
CLINICAL CANCER RESEARCH, 2016, 22 (12) :3025-3036
[5]   Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer [J].
Bowtell, David D. ;
Boehm, Steffen ;
Ahmed, Ahmed A. ;
Aspuria, Paul-Joseph ;
Bast, Robert C., Jr. ;
Beral, Valerie ;
Berek, Jonathan S. ;
Birrer, Michael J. ;
Blagden, Sarah ;
Bookman, Michael A. ;
Brenton, James D. ;
Chiappinelli, Katherine B. ;
Martins, Filipe Correia ;
Coukos, George ;
Drapkin, Ronny ;
Edmondson, Richard ;
Fotopoulou, Christina ;
Gabra, Hani ;
Galon, Jerome ;
Gourley, Charlie ;
Heong, Valerie ;
Huntsman, David G. ;
Iwanicki, Marcin ;
Karlan, Beth Y. ;
Kaye, Allyson ;
Lengyel, Ernst ;
Levine, Douglas A. ;
Lu, Karen H. ;
McNeish, Iain A. ;
Menon, Usha ;
Narod, Steven A. ;
Nelson, Brad H. ;
Nephew, Kenneth P. ;
Pharoah, Paul ;
Powell, Daniel J., Jr. ;
Ramos, Pilar ;
Romero, Iris L. ;
Scott, Clare L. ;
Sood, Anil K. ;
Stronach, Euan A. ;
Balkwill, Frances R. .
NATURE REVIEWS CANCER, 2015, 15 (11) :668-679
[6]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[7]   Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss [J].
Clarke, Blaise ;
Tinker, Anna V. ;
Lee, Cheng-Han ;
Subramanian, Subbaya ;
van de Rijn, Matt ;
Turbin, Dmitry ;
Kalloger, Steve ;
Han, Guangming ;
Ceballos, Kathy ;
Cadungog, Mark G. ;
Huntsman, David G. ;
Coukos, George ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :393-402
[8]   Potent immunogenicity in BRCA1-mutated patients with high-grade serous ovarian carcinoma [J].
Dai, Ying ;
Sun, Chengdu ;
Feng, Yi ;
Jia, Qingzhu ;
Zhu, Bo .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) :3979-3986
[9]   Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures [J].
Dieu-Nosjean, Marie-Caroline ;
Antoine, Martine ;
Danel, Claire ;
Heudes, Didier ;
Wislez, Marie ;
Poulot, Virginie ;
Rabbe, Nathalie ;
Laurans, Ludivine ;
Tartour, Eric ;
de Chaisemartin, Luc ;
Lebecque, Serge ;
Fridman, Wolf-Herman ;
Cadranel, Jacques .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) :4410-4417
[10]   PTEN functions as a melanoma tumor suppressor by promoting host immune response [J].
Dong, Y. ;
Richards, J-A E. ;
Gupta, R. ;
Aung, P. P. ;
Emley, A. ;
Kluger, Y. ;
Dogra, S. K. ;
Mahalingam, M. ;
Wajapeyee, N. .
ONCOGENE, 2014, 33 (38) :4632-4642